Keywords: meningitis, vaccine, recall, over, aureus, contamination, switzerland-based

Meningitis vaccine recall over S. aureus contamination

Article | 02 March 2009

Switzerland-based drug major Novartis has issued a product recall for 21,000 doses of its Menjugate Kit, a meningitis C conjugate vaccine, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in